Orbit Biomedical brings precise, targeted surgical delivery to the rapidly progressing field of gene and cell therapy

The company’s technology platform and clinical training has the potential to transform the accuracy, safety and consistency of delivering curative therapeutics, including gene therapies, enabling enhanced benefits to patients.

Orbit Biomedical’s current focus is on delivery to the sub-retinal space for the treatment of retinal diseases. Located in Philadelphia, Orbit Biomedical was founded in 2018.

Developing

Company Details

Latest updates

There are currently no updates for Orbit Biomedical.